Act Two Investors LLC bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,790 shares of the company’s stock, valued at approximately $1,848,000. Johnson & Johnson makes up about 0.4% of Act […]